131 related articles for article (PubMed ID: 38206631)
1. Mirtazapine as Appetite Stimulant in Patients With Non-Small Cell Lung Cancer and Anorexia: A Randomized Clinical Trial.
Arrieta O; Cárdenas-Fernández D; Rodriguez-Mayoral O; Gutierrez-Torres S; Castañares D; Flores-Estrada D; Reyes E; López D; Barragán P; Soberanis Pina P; Cardona AF; Turcott JG
JAMA Oncol; 2024 Mar; 10(3):305-314. PubMed ID: 38206631
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial.
Hunter CN; Abdel-Aal HH; Elsherief WA; Farag DE; Riad NM; Alsirafy SA
J Pain Symptom Manage; 2021 Dec; 62(6):1207-1215. PubMed ID: 34051293
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial.
Chowdhury IH; Rahman MS; Chowdhury MNK; Afroze YJ; Tabassum M; Marnush M; Zerin N
Jpn J Clin Oncol; 2024 May; 54(5):530-536. PubMed ID: 38323684
[TBL] [Abstract][Full Text] [Related]
4. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
5. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial.
Turcott JG; Del Rocío Guillen Núñez M; Flores-Estrada D; Oñate-Ocaña LF; Zatarain-Barrón ZL; Barrón F; Arrieta O
Support Care Cancer; 2018 Sep; 26(9):3029-3038. PubMed ID: 29550881
[TBL] [Abstract][Full Text] [Related]
6. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
9. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
[TBL] [Abstract][Full Text] [Related]
10. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.
Coffin PO; Santos GM; Hern J; Vittinghoff E; Walker JE; Matheson T; Santos D; Colfax G; Batki SL
JAMA Psychiatry; 2020 Mar; 77(3):246-255. PubMed ID: 31825466
[TBL] [Abstract][Full Text] [Related]
11. Appetite stimulants for people with cystic fibrosis.
McTavish D; Thornton J
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008190. PubMed ID: 36149378
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
13. Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer.
Sandhya L; Devi Sreenivasan N; Goenka L; Dubashi B; Kayal S; Solaiappan M; Govindarajalou R; Kt H; Ganesan P
J Clin Oncol; 2023 May; 41(14):2617-2627. PubMed ID: 36977285
[TBL] [Abstract][Full Text] [Related]
14. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
Yeh SS; Lovitt S; Schuster MW
J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
Quimby JM; Lunn KF
Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
[TBL] [Abstract][Full Text] [Related]
16. Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
Han B; Li K; Wang Q; Zhang L; Shi J; Wang Z; Cheng Y; He J; Shi Y; Zhao Y; Yu H; Zhao Y; Chen W; Luo Y; Wu L; Wang X; Pirker R; Nan K; Jin F; Dong J; Li B; Sun Y
JAMA Oncol; 2018 Nov; 4(11):1569-1575. PubMed ID: 30098152
[TBL] [Abstract][Full Text] [Related]
17. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer.
Currow DC; Glare P; Louw S; Martin P; Clark K; Fazekas B; Agar MR
Sci Rep; 2021 Jan; 11(1):2421. PubMed ID: 33510313
[TBL] [Abstract][Full Text] [Related]
19. Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial.
Zhou C; Wang Z; Sun Y; Cao L; Ma Z; Wu R; Yu Y; Yao W; Chang J; Chen J; Zhuang W; Cui J; Chen X; Lu Y; Shen H; Wang J; Li P; Qin M; Lu D; Yang J
Lancet Oncol; 2022 Feb; 23(2):220-233. PubMed ID: 35038432
[TBL] [Abstract][Full Text] [Related]
20. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Banerjee S; Farina N; Henderson C; High J; Stirling S; Shepstone L; Fountain J; Ballard C; Bentham P; Burns A; Fox C; Francis P; Howard R; Knapp M; Leroi I; Livingston G; Nilforooshan R; Nurock S; O'Brien J; Price A; Thomas AJ; Swart AM; Telling T; Tabet N
Health Technol Assess; 2023 Oct; 27(23):1-108. PubMed ID: 37929672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
